Condition

Auditory Hallucinations

ClinicalTrials.gov condition label

Clinical trials10

Recruiting0

Common interventions18

Lead sponsors shown10

Clinical trials

10 shown

LIFU Effects & Outcomes: Mechanisms Evaluating Striatal Systems Imaging (LEO MESSI)NCT07710989 · 2027-02-01

NOT_YET_RECRUITING

Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic DisorderNCT07134816 · 2025-08-01

NOT_YET_RECRUITING

Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory HallucinationsNCT06628323 · 2024-11-12

ACTIVE_NOT_RECRUITING

Auditory Control Enhancement (ACE) in SchizophreniaNCT06155695 · 2023-09-05

CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality TherapyNCT04661163 · 2020-11-16

Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst StimulationNCT02670291 · 2017-01-01

Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaNCT01963676 · 2014-01-01

Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia PatientsNCT02240446 · 2013-06-01

Transcranial Direct Current Stimulation (tDCS) and Hallucinations in SchizophreniaNCT00870909 · 2009-02-02

A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With ClozapineNCT01015001 · 2008-05-01

Common interventions

(1Hz) rTMS applied over the left temporoparietal cortexPROCEDURE1 Active rTMS x sham (placebo) rTMSPROCEDURE1 Active tDCSDEVICE1 active tDCSPROCEDURE1 Auditory Cognitive Control Training (ACCT)BEHAVIORAL1 Cognitive and behavioral therapy for auditory hallucinationsOTHER1 LIFUDEVICE1 MagPro Cool-B65A/P, MagventureDEVICE1 PsychotherapyOTHER1 sham rTMSPROCEDURE1 Sham stimulationDEVICE1 Sham tDCSDEVICE1 sham tDCSPROCEDURE1 tDCSDEVICE1 Transcranial Direct Current Stimulation (tDCS)DEVICE1 Usual treatmentOTHER1 Virtual Reality-based InterventionBEHAVIORAL1 Virtual Reality-based Intervention employing NeurofeedbackBEHAVIORAL1

Leading sponsors

Brian A Coffman, PhD1 Hôpital le Vinatier1 Hospital de Clinicas de Porto Alegre1 Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital1 University Hospital Bispebjerg and Frederiksberg1 University Hospital Tuebingen1 University Hospital, Montpellier1 University of California, San Francisco1 University of Minnesota1 University of North Carolina, Chapel Hill1

Trial status mix

COMPLETED5

NOT_YET_RECRUITING2

ACTIVE_NOT_RECRUITING1

TERMINATED1

WITHDRAWN1

Phase mix

NA9

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.